Biocompatible de novo indolylchalcones as platelet aggregation inhibition and diabetic wound healing agents
{{output}}
Cardiovascular diseases and chronic wounds, particularly in diabetic patients, pose significant therapeutic challenges due to impaired vascular function, persistent inflammation, and delayed tissue repair. Nitric oxide synthase (NOS) activation and platelet ag... ...
